GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » ROA %

Lobe Sciences (XCNQ:LOBE) ROA % : -110.72% (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Lobe Sciences's annualized Net Income for the quarter that ended in Feb. 2024 was C$-2.38 Mil. Lobe Sciences's average Total Assets over the quarter that ended in Feb. 2024 was C$2.15 Mil. Therefore, Lobe Sciences's annualized ROA % for the quarter that ended in Feb. 2024 was -110.72%.

The historical rank and industry rank for Lobe Sciences's ROA % or its related term are showing as below:

XCNQ:LOBE' s ROA % Range Over the Past 10 Years
Min: -800   Med: -94.37   Max: -22.41
Current: -59.87

During the past 13 years, Lobe Sciences's highest ROA % was -22.41%. The lowest was -800.00%. And the median was -94.37%.

XCNQ:LOBE's ROA % is ranked worse than
68.19% of 1550 companies
in the Biotechnology industry
Industry Median: -34.765 vs XCNQ:LOBE: -59.87

Lobe Sciences ROA % Historical Data

The historical data trend for Lobe Sciences's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences ROA % Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.41 -34.90 -77.05 -176.99 -232.62

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -496.95 -300.11 - -101.23 -110.72

Competitive Comparison of Lobe Sciences's ROA %

For the Biotechnology subindustry, Lobe Sciences's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's ROA % distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's ROA % falls into.



Lobe Sciences ROA % Calculation

Lobe Sciences's annualized ROA % for the fiscal year that ended in Aug. 2023 is calculated as:

ROA %=Net Income (A: Aug. 2023 )/( (Total Assets (A: Aug. 2022 )+Total Assets (A: Aug. 2023 ))/ count )
=-4.707/( (1.748+2.299)/ 2 )
=-4.707/2.0235
=-232.62 %

Lobe Sciences's annualized ROA % for the quarter that ended in Feb. 2024 is calculated as:

ROA %=Net Income (Q: Feb. 2024 )/( (Total Assets (Q: Nov. 2023 )+Total Assets (Q: Feb. 2024 ))/ count )
=-2.38/( (2.19+2.109)/ 2 )
=-2.38/2.1495
=-110.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2024) net income data. ROA % is displayed in the 30-year financial page.


Lobe Sciences  (XCNQ:LOBE) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Feb. 2024 )
=Net Income/Total Assets
=-2.38/2.1495
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.38 / 0)*(0 / 2.1495)
=Net Margin %*Asset Turnover
=N/A %*0
=-110.72 %

Note: The Net Income data used here is four times the quarterly (Feb. 2024) net income data. The Revenue data used here is four times the quarterly (Feb. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Lobe Sciences ROA % Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines